Description

3-Ethyl-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-2-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol is a complex, multi-cyclic organic compound belonging to the benzoquinolizine class, serving as a critical advanced pharmaceutical intermediate or research chemical. Its intricate molecular architecture makes it a valuable building block for the synthesis of specialized fine chemicals and active pharmaceutical ingredients (APIs). This product is primarily targeted at pharmaceutical R&D laboratories, contract manufacturing organizations (CMOs), and academic research institutions engaged in medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the development of novel therapeutic agents, particularly in central nervous system (CNS) or cardiovascular research.
• Medicinal Chemistry Research: Used as a core scaffold or building block for structure-activity relationship (SAR) studies and library synthesis.
• Process Chemistry & Scale-Up: Serves as a critical intermediate for optimizing synthetic routes and scaling up production for clinical trial materials.
• Reference Standard: Employed as an analytical standard for quality control and method validation in API manufacturing.
• Biochemical Research: Potential tool compound for investigating biological pathways and enzyme interactions due to its specific alkaloid-like structure.
• Fine Chemical Synthesis: Intermediate for creating complex, high-value specialty chemicals used in agrochemicals or material science.

Basic Information

Product Name	3-Ethyl-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-2-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
CAS No.	58261-35-1
Molecular Formula	C22H33NO3
Molecular Weight	359.51 g/mol
Synonyms	2H-Benzo[a]quinolizin-2-ol, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-(2-methylpropyl)-; 3-Ethyl-9,10-dimethoxy-2-isobutyl-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-ol; Benzo[a]quinolizin-2-ol derivative; 58261-35-1; UNII-7VJ280552N
EINECS	Contact for details

Quality Control

Our 3-Ethyl-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-2-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS). A detailed Certificate of Analysis (COA) is provided with every shipment, ensuring traceability and compliance with your research or cGMP guidelines for intermediates. Specifications can be aligned with client requirements for custom synthesis projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize moisture uptake. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.